We anticipate BAUSCH + LOMB INFUSE will be available to eye care practitioners in the second half of 2020.”īausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., is solely focused on helping people see. A low modulus (stiffness) reduces the impact on the front of the eye to provide a comfortable lens-wearing experience. High oxygen transmissibility (Dk/t) helps maintain a balance of the front of the eye and keeps the open eye healthy and white. As with any contact lens, problems can result in serious injury to the eye, including loss of vision, and clinical studies have shown that the risk of serious adverse reactions is increased when lenses are worn overnight.
#BAUSCH AND LOMB INFUSE CONTACT LENSES FULL#
“We are excited to add this breakthrough new SiHy daily contact lens to our portfolio and provide the outstanding health, vision and comfort that practitioners expect and patients deserve from Bausch + Lomb. From Bausch + Lomb INFUSE maintains 96 of its moisture for a full 16 hours. ♫AUSCH + LOMB ULTRA contact lenses are indicated for daily wear or extended wear of up to seven days. “Bausch + Lomb continues to push the innovation curve in the contact lens space with the FDA’s clearance of BAUSCH + LOMB INFUSE,” said Joe Gordon, U.S. Engineered with Bausch + Lomb’s most advanced proprietary contact lens technologies, BAUSCH + LOMB INFUSE offers outstanding breathability for healthy lens wear while providing exceptional all-day comfort and high definition optics. Food and Drug Administration (FDA) for BAUSCH + LOMB INFUSE™ daily disposable silicone hydrogel (SiHy daily) contact lenses.īAUSCH + LOMB INFUSE contact lenses feature a next generation contact lens material (kalifilcon A), which is designed to meet the unmet needs of contact lens wearers, including those who experience contact lens dryness. Bausch + Lomb Bonus Offer RebateSave up to 300 Save up to 300 on an annual supply of contact lenses. (NYSE/TSX: BHC) (“Bausch Health”), today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration)īausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. The US FDA’s Center for Devices and Radiological Health. BAUSCH + LOMB INFUSE contact lenses feature a next generation contact lens material (kalifilcon A), which is designed to meet the unmet needs of contact lens wearers, including those who experience contact lens dryness
0 kommentar(er)
